Skip to main content

Today’s BIG headline “Khloé Kardashian Addresses Accusations She Uses Diabetes Medication for Weight Loss!”

bŏdze Plastic surgery wants to weigh in on the controversy and give you some insider information regarding the diabetes medication being referenced, what the drug is used for, and why people are upset about Khloe’s alleged use.

Here are some of the comments left on Khloé Kardashian’s page:

“Ozempic ozempic ozempic ozempic ozempic ozempic ozempic did you have your shot to day?” one accusation read, while another simply said, “O-o-ozempic!”

“you cake yourself in makeup to workout in your own home at 6am?? come on you’re not fooling anyone you’ve worked out for years and were never this thin and kim certainly is not working out alot! you’re both on diabetic medication! people in your industry have been speaking about it for months it’s not even a secret, your family makes millions influencing young girls you should have a conscience,” said another.

Check out Khloe’s Instagram by clicking here:

https://www.instagram.com/khloekardashian/feed/?hl=en

“Save the Ozempic for the diabetics who need it,” scolded a fourth.

bŏdze plastic surgery center does not condone negative comments. We believe in creating a safe space for our patients and community to openly discuss questions and concerns while offering unrestricted access to our inside industry information. 

Here are the facts:

The medication being referenced is a Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, it is an antidiabetic medication used for the treatment of type 2 diabetes and as anti-obesity medication for long-term weight management, developed by Novo Nordisk in 2012.

This medication belongs to a class of medications called GLP-1 agonists. These compounds replicate a hormone we all make in our intestines that is released after we start eating. Semaglutide increases insulin release in response to glucose intake and causes a minor delay in gastric emptying- it also acts in areas of the brain involved in regulating appetite and food intake. The medication also makes your body more sensitive to the insulin that you produce on your own. By doing that it helps your body’s fat cells shrink over time.

Furthermore,

Novo Nordisk produces both the semaglutide Ozempic and Wegovy, which, while approved for two different purposes, are in fact similar. Semaglutide 1 mg (Ozempic) is a once-weekly injection FDA approved to treat diabetes since 2017. A higher 2 mg dose was approved in early 2022; that medication is called Wegovy and is a higher dose of the weekly semaglutide (2.4 mg) and was approved for the treatment of obesity in July 2021.

Here is where the controversy starts and our response to relevancy of the topic:

1.) Is it appropriate to use Ozempic for weight loss when the drug was originally designed for diabetes patients?

The short answer, NO- it is not appropriate to use Ozempic for weight loss medication if Wagovy or another suitable medication is available. However, we have included information regarding obesity and weight loss below; your provider will further elaborate on what their recommendations are based on your medical history.

Don’t forget that..

One of the leading causes for diabetes is obesity. Your provider took an oath to be your advocate- and our job in the healthcare industry is to find the best solutions to encourage a healthy, balanced, and fulfilled life for our patients. Because Ozempic is not approved for weight loss, it is not appropriate to prescribe this drug if there is an available alternative.

Wegovy may be one solution to appropriately treating obesity in patients that are seeking a long-term, low Maintenace, weight loss alternative. Wagovy claims that “The brain plays a critical role in appetite regulation” and poses the question in their literature, “Is it time to stop blaming weight regain on lack of willpower?”

novo nordisk, the makers of Wagovy claim, “sustaining weight loss can be hard because of the metabolic adaptation” and may not be due to the lack of self-control or Maintenace of a calorie-restricted diet.

More than 40% of Americans age 20 or older have obesity, and this can lead to increased health risks and complications.

Here is a list provided by novo nordisk that illustrates comorbidities that obesity may cause or worsen:
  • Type 2 diabetes
  • Diabetes risk, prediabetes
  • Dyslipidemia
  • Hypertension
  • Cardiovascular disease
  • NAFLD
  • Female infertility, including PCOS
  • Male hypogonadism
  • OSA
  • Asthma
  • Osteoarthritis
  • Urinary stress incontinence
  • Depression
  • GERD

Check out information from the source:

https://www.novonordisk-us.com/products/product-supply-update.html

Patients that have support from their healthcare team lost more than 5x more weight than with a self-directed program in a study conducted by novo nordisk. 

2.) Should Khloé Kardashian particularly be taking Ozempic or Wagovy?

Ozempic and Wagovy are cleared to treat patients who are obese, which would be defined as a patient with a BMI of 30 or higher. According to Healthycelebrity.com Khloé Kardashian is rumored to be 5’10 and 170 pounds which would put her BMI at 24.39 and be considered a normal weight. If this is true- it would not be appropriate to prescribe Miss. Kardashian a weight loss drug unless there was an underlying condition the drug was addressing.

Vanity fair reports, Kardashian was quick to clap back in a now-deleted response. “Let’s not discredit my years of working out. I get up 5 days a week at 6am to train. Please stop with your assumptions,” she reportedly responded to one of the countless comments, adding, “I guess a new year still means mean people.”

It’s unclear where the assumption came from, but Kim Kardashian was accused of using the same drug to help her fit into Marilyn Monroe’s dress last year.

3.) Does bŏdze support the use of these medications for weight loss?

Yes. bŏdze has a wellness-based approach to every service we offer. We believe in the conservation of conservatism and have a proven method for delivering long-lasting results built on accountability, follow-up, patient participation, and getting to the root of the problem. 

We require a series of tests before creating a customized weight loss program for our patients and often discover what deficiencies may be contributing to their inability to either lose weight to maintain weight loss. Many times, the fix is simple, other times we may prescribe drugs such as Wagovy to help our obese patients achieve a healthy weight.

 

If you’re interested in being placed on our exclusive blog invitation list, please fill out the form below.

 

Name(Required)
Address
How did you hear about bŏdze?

This field is for validation purposes and should be left unchanged.